The stethoscope just got a little bit stronger thanks to Eko obtaining a new FDA clearance. The Oakland, CA-based company said its Eko Murmur Analysis Software (EMAS) for detecting and characterizing murmurs found in adults and pediatric patients is now ready for the market.
"This clearance gives us the ability to commercialize and get into market a novel heart disease detection AI algorithm that allows physicians to use their stethoscope with more confidence and be able to detect signs of cardiovascular disease like valvular heart disease, " Connor Landgraf, Co-founder & CEO of Eko, told MD+DI.
Read more at MD+DI
Please note: Murmur detection is part of Eko’s SENSORA™ Cardiac Disease Detection Platform. Contact our sales team to learn more.